Trial · NCT00653328
Adverse events84
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 84
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Hemoglobin | Blood and lymphatic system disorders | Altrasentan + Doxil | 7 | 15 | 50 |
| other | fatigue | General disorders | Altrasentan + Doxil | 10 | 15 | 34 |
| other | Hypoalbuminemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Altrasentan + Doxil | 1 | 15 | 1 |
| other | Hyponatremia | Metabolism and nutrition disorders | Altrasentan + Doxil | 1 | 15 | 2 |
| other | pelvic pain | Reproductive system and breast disorders | Altrasentan + Doxil | 2 | 15 | 2 |
| other | Urinary urgency | Renal and urinary disorders | Altrasentan + Doxil | 1 | 15 | 2 |
| other | Nausea | Gastrointestinal disorders | Altrasentan + Doxil | 5 | 15 | 8 |
| other | Vomiting | Gastrointestinal disorders | Altrasentan + Doxil | 4 | 15 | 5 |
| other | Abdominal Pain | Gastrointestinal disorders | Altrasentan + Doxil | 4 | 15 | 4 |
| other | Dyspnea | Respiratory, thoracic and mediastinal disorders | Altrasentan + Doxil | 8 | 15 | 11 |
| other | Hot flashes | Vascular disorders | Altrasentan + Doxil | 2 | 15 | 2 |
| other | Allergic Rhinitis | Respiratory, thoracic and mediastinal disorders | Altrasentan + Doxil | 3 | 15 | 5 |
| other | Leukocytes | Blood and lymphatic system disorders | Altrasentan + Doxil | 4 | 15 | 29 |
| other | neutrophils, granulocytes | Investigations | Altrasentan + Doxil | 2 | 15 | 25 |
| other | platelets | Investigations | Altrasentan + Doxil | 1 | 15 | 14 |
| other | arrhythmias | Cardiac disorders | Altrasentan + Doxil | 1 | 15 | 1 |
| other | edema | General disorders | Altrasentan + Doxil | 8 | 15 | 13 |
| other | hypotension | Vascular disorders | Altrasentan + Doxil | 2 | 15 | 2 |
| other | fever | General disorders | Altrasentan + Doxil | 2 | 15 | 2 |
| other | rigors, chills | General disorders | Altrasentan + Doxil | 1 | 15 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00653328/events